TITLE

Modeling Biotransformation Reactions by Combined Quantum Mechanical / Molecular Mechanical Approaches: From Structure to Activity

AUTHOR(S)
L. Ridder; A.J. Mulholland
PUB. DATE
July 2003
SOURCE
Current Topics in Medicinal Chemistry;Jul2003, Vol. 3 Issue 11, p1241
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
An overview of the combined quantum mechanical / molecular mechanical (QM / MM) approach and its application to studies of biotransformation enzymes and drug metabolism is given. Theoretical methods to simulate enzymatic reactions have rapidly developed during the last decade. In particular, QM / MM methods provide detailed insights into enzyme catalyzed reactions, which can be extremely valuable in complementing experimental research. QM / MM methods allow the reacting groups in the active site of an enzyme to be studied at a quantum mechanical level, while the surrounding protein and solvent is included at a classical (and computationally less expensive) molecular mechanical level. Existing QM / MM implementations vary in the level of interaction between the QM and MM regions and in the way the partitioning into QM and MM regions is setup. Some general considerations concerning reaction modeling are discussed and a number of QM / MM studies related to drug metabolism are described. These studies illustrate that theoretical modeling of important metabolic reactions provides detailed insights into mechanisms of reaction and specific catalytic effects of enzyme residues as well as explaining variation in rates of conversion of different metabolites. Such information is essential in the development of methods to predict metabolism of drugs and to understand metabolic effects of genetic polymorphism in biotransformation enzymes.
ACCESSION #
10244760

 

Related Articles

  • Tumoral Drug Metabolism: Perspectives and Therapeutic Implications. M.M. Doherty; M. Michael // Current Drug Metabolism;Apr2003, Vol. 4 Issue 2, p131 

    Drug metabolising enzymes (DME) in tumors are capable of biotransforming a variety of xenobiotics. Over a long period of time, many studies have reported the presence of DME in tumors, however quantitation and sampling techniques and heterogeneous patient populations have resulted in many...

  • Foreign Compounds and Intermediary Metabolism: Sulfoxidation Bridges the Divide. Mitchell, S. C.; Steventon, G. B. // Current Drug Metabolism;Mar2009, Vol. 10 Issue 3, p220 

    It is widely appreciated that as a xenobiotic travels through an organism and interacts with the biochemical machinery of a living system, it most probably will undergo a number of metabolic alterations usually leading to a cluster of differing chemical species. Indeed, the modern 'metabonomic'...

  • Pharmacogenetics, Regulation and Structural Properties of the Drugmetabolizing Enzymes Arylamine N-acetyltransferases. Dupret, Jean-Marie; Dairou, Julien; Atmane, Noureddine; Rodrigues-Lima, Fernando // Current Pharmacogenomics;Dec2004, Vol. 2 Issue 4, p333 

    Xenobiotic-metabolizing enzymes (XME) are responsible for the biotransformation of a vast range of compounds. Arylamine N-acetyltransferases (NAT) are XME responsible for the acetylation of many arylamine and heterocyclic amines. They therefore, play an important role in the detoxification and...

  • Multiple Species Metabolism of PHA-568487, A Selective a7 Nicotinic Acetylcholine Receptor Agonist. Shilliday, F. Barclay; Walker, Daniel P.; Chungang Gu; Xiaojun Fang; Thornburgh, Bruce; Fate, Gwendolyn D.; Daniels, J. Scott // Drug Metabolism Letters;Aug2010, Vol. 4 Issue 3, p163 

    The quinuclidine PHA-0568487(1) is an agonist of the alpha7 nicotinic acetylcholine receptor that was designed to mitigate the bioactivation associated with the core scaffold and subsequently remove associated liabilities with in vivo tolerability. The drug metabolites of 1 in nonclinical...

  • Accurate Mass: Why It's the Best Solution for Metabolite Identification in Discovery, Development, and Clinical Applications. Tiller, Philip R. // Spectroscopy;Mar2012 Supplement, p12 

    The article discusses on significance of analysis of accurate mass over nominal-mass in identification of metabolites. It mentions that accurate mass-based analysis helps in differentiation between analytes of interest and the matrix, understanding nature of biotransformation and in determining...

  • Pharmacogenetics of Phase I and Phase II Drug Metabolism. Crettol, Severine; Petrovic, Nenad; Murray, Michael // Current Pharmaceutical Design;1/11/2010, Vol. 16 Issue 2, p204 

    Genetic variation in the receptors and other intracellular targets that mediate the pharmacodynamic effects of drugs can affect therapeutic outcomes. However, at present greater knowledge is available concerning the extent of gene variation in drug metabolizing enzymes that determine drug...

  • Polymorphic Drug Metabolism in Anaesthesia. Restrepo, Juan G.; Garcia-Martín, Elena; Martínez, Carmen; Agúndez, José A. G. // Current Drug Metabolism;Mar2009, Vol. 10 Issue 3, p236 

    A substantial part of the interindividual variability in response to drugs and xenobiotics is related to genetically-determined impairment in drug metabolism. Several drug-metabolising enzymes are polymorphic in humans and often polymorphisms are strongly related to altered drug biodisposition...

  • A Unique Example of Drug Metabolism: Tetra- and Penta-Oxygenation Reactions of Capravirine in Rats, Dogs and Humans. Hai-Zhi Bu; Pool, William F.; Wu, Ellen Y.; Shetty, Bhasker V. // Drug Metabolism Letters;Jan2007, Vol. 1 Issue 1, p61 

    Six tetra- and two penta-oxygenated capravirine metabolites observed in rats, dogs and humans represent the maximum numbers of isomers that can be predicted since oxygenations are restricted at the pyridinyl nitrogen (N-oxidation), sulfur (sulfoxidation), and isopropyl group (hydroxylation),...

  • Structure and Mechanism of Arylamine N-Acetyltransferases. Westwood, I. M.; Kawamura, A.; Fullam, E.; Russell, A. J.; Davies, S. G.; Sim, E. // Current Topics in Medicinal Chemistry;Aug2006, Vol. 6 Issue 15, p1641 

    Arylamine N-acetyltransferases (NATs) are a family of phase II drug-metabolising enzymes which are important in the biotransformation of various aromatic and heterocyclic amines and hydroxylamines, arylhydrazines and arylhydrazides. NATs are present in a wide range of eukaryotes and prokaryotes....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics